Bladder Cancer

Prognostic DNA Methylation Biomarkers in High-risk Non-muscle-invasive Bladder Cancer: A Systematic Review to Identify Loci for Prospective Validation. - Beyond the Abstract March 28, 2019

Determinants of Guideline-Based Treatment in Patients With cT1 Bladder Cancer - Beyond the Abstract March 26, 2019

Gynecologic Organ Involvement During Radical Cystectomy for Bladder Cancer: Is It Time to Routinely Spare the Ovaries? - Beyond the Abstract February 22, 2019

Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy - Beyond the Abstract February 22, 2019

The Development of Interferon-Based Gene Therapy for BCG Unresponsive Bladder Cancer: From Bench to Bedside – Beyond the Abstract February 6, 2019

Contemporary Grading and Staging of Urothelial Neoplasms of the Urinary Bladder: New Concepts and Approaches to Challenging Scenarios - Beyond the Abstract January 16, 2019

A risk-stratified Approach to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Implications for Patients Classified with Low-risk Disease - Beyond the Abstract January 15, 2019

Molecular Footprints of Muscle-Invasive Bladder Cancer in Smoking and Nonsmoking Patients - Beyond the Abstract December 10, 2018

Transcriptomic and Protein Analysis of Small Cell Bladder Cancer Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic Target - Beyond the Abstract December 9, 2018

Implications of Micropapillary Urothelial Carcinoma Variant on Prognosis Following Radical Cystectomy: A Multi-Institutional Investigation – Beyond the Abstract December 9, 2018

Performance Measurement and Quality Improvement Initiatives for Bladder Cancer Care - Beyond the Abstract November 9, 2018

Impact of Neoadjuvant Chemotherapy on Pathologic Response in Patients With Upper Tract Urothelial Carcinoma Undergoing Extirpative Surgery - Beyond the Abstract November 7, 2018

Association Between Heat Shock Proteins 60 and 70 and Long-Term Outcomes of T1-Stage High-Grade Urothelial Tumors Treated with BCG - Beyond the Abstract November 6, 2018

Clonal Relatedness and Mutational Differences Between Upper Tract and Bladder Urothelial Carcinoma - Beyond the Abstract November 1, 2018

Asymptomatic Recurrence Detection and Cost-Effectiveness in Urothelial Carcinoma - Beyond the Abstract October 29, 2018

Narrow Band Imaging Reduces Persistence of Cancer in Patients with pT1 High Grade Bladder Cancer - Beyond the Abstract August 28, 2018

Outcomes of Radiosensitisation in Elderly Patients with Advanced Bladder Cancer – Beyond the Abstract August 6, 2018

Does the Gross Prosector Impact pT3 Subclassification or Lymph Node Counts in Bladder Cancer? – Beyond the Abstract August 6, 2018

Combination Intravesical Chemotherapy for Non-Muscle-Invasive Bladder Cancer - Beyond the Abstract July 31, 2018

Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials: Focus on Efficacy, Safety, and Response to Subsequent Therapies - Beyond the Abstract June 29, 2018

Page 1 of 11

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Bladder Cancer

Free Daily and Weekly newsletters offered by content of interest

Login